D3‐Creatine dilution and the importance of accuracy in the assessment of skeletal muscle mass
Open accessThe DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
Sarcopenia has been described as the age‐associated decrease in skeletal muscle mass. However, virtually every study of sarcopenia has measured lean body mass (LBM) or fat free mass (FFM) rather than muscle mass, specifically. In a number of published sarcopenia studies, LBM or FFM is referred to as muscle mass, leading to an incorrect assumption that measuring LBM or FFM is an accurate measure of muscle mass. As a result, the data on the effects of changes in LBM or FFM in older populations on outcomes such as functional capacity, disability, and risk of injurious falls have been inconsistent resulting in the conclusion that muscle mass is only weakly related to these outcomes. We review and describe the assumptions for the most commonly used measurements of body composition. Dual‐energy X‐ray absorptiometry (DXA) has become an increasingly common tool for the assessment of LBM or FFM and appendicular lean mass as a surrogate, but inaccurate, measurement of muscle mass. Other previously used methods (total body water, bioelectric impedance, and imaging) also have significant limitations. D 3‐Creatine (D 3‐Cr) dilution provides a direct and accurate measurement of creatine pool size and skeletal muscle mass. In a recent study in older men (MrOS cohort), D 3‐Cr muscle mass was associated with functional capacity and risk of injurious falls and disability, while assessments of LBM or appendicular lean mass by DXA were only weakly or not associated with these outcomes. Inaccurate measurements of muscle mass by DXA and other methods have led to inconsistent results and potentially erroneous conclusions about the importance of skeletal muscle mass in health and disease. The assessment of skeletal muscle mass using the D 3‐Cr dilution method in prospective cohort studies may reveal sarcopenia as a powerful risk factor for late life disability and chronic disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Epidemiology of Sarcopenia among the Elderly in New Mexico
Baumgartner, R. N., Koehler, K. M., Gallagher, D., Romero, L., Heymsfield, S. B., Ross, R. R., Garry, P. J., & Lindeman, R. D. (1998) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009520 · Cited by 4,004 · cited 2×
“Baumgartner et al.4 were the first to use DXAbased measures of lean mass to operationalize a definition of sarcopenia, which demonstrated that low lean mass of the arms and legs (appendicular lean mass) was associated with worse functional status (although imputed DXA data were used for some participants).”
BackgroundFielding, R. A., Vellas, B., Evans, W. J., Bhasin, S., Morley, J. E., Newman, A. B., Abellan van Kan, G., Andrieu, S., Bauer, J., Breuille, D., et al. (2011) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2011.01.003 · Cited by 3,256
Self-citationJanssen, I., Heymsfield, S. B., & Ross, R. (2002) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2002.50216.x · Cited by 3,139 · cited 2×
“Janssen et al.(18) used BIA data collected on 4504 men and women over the age of 60 years in the Third National Health and Nutrition Examination Survey to estimate the prevalence of sarcopenia.”
MethodStudenski, S. A., Peters, K. W., Alley, D. E., Cawthon, P. M., McLean, R. R., Harris, T. B., Ferrucci, L., Guralnik, J. M., Fragala, M. S., Kenny, A. M., et al. (2014) · The Journals of Gerontology: Series A · doi:10.1093/gerona/glu010 · Cited by 2,545 · cited 1×
“Sarcopenia undertook a data-analysis based effort to better define diagnostic criteria for sarcopenia.(27) Using DXA derived appendicular lean mass from multiple cohort studies in older people, Cawthon et al.”
MethodSelf-citationCruz-Jentoft, A. J., Landi, F., Schneider, S. M., Zuniga, C., Arai, H., Boirie, Y., Chen, L.-K., Fielding, R. A., Martin, F. C., Michel, J.-P., et al. (2014) · Age and Ageing · doi:10.1093/ageing/afu115 · Cited by 1,963
Shen, W., Punyanitya, M., Wang, Z., Gallagher, D., St.-Onge, M.-P., Albu, J., Heymsfield, S. B., & Heshka, S. (2004) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00744.2004 · Cited by 1,692 · cited 1×
“tomic composition and use of multiple CT or MRI slices can provide estimates of volume of muscle or fat tissues.(20) CT has also been useful in estimating the lipid content of”
BackgroundNewman, A. B., Kupelian, V., Visser, M., Simonsick, E. M., Goodpaster, B. H., Kritchevsky, S. B., Tylavsky, F. A., Rubin, S. M., Harris, T. B., & on Behalf of the Health, A. A. B. C. S. I. (2006) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/61.1.72 · Cited by 1,692
Sarcopenia with limited mobility: an international consensus
Morley, J. E., Abbatecola, A. M., Argiles, J. M., Baracos, V., Bauer, J., Bhasin, S., Cederholm, T., Stewart Coats, A. J., Cummings, S. R., Evans, W. J., et al. (2011) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2011.04.014 · Cited by 1,125
Self-citationSarcopenia: alternative definitions and associations with lower extremity function
Newman, A. B., Kupelian, V., Visser, M., Simonsick, E., Goodpaster, B., Nevitt, M., Kritchevsky, S. B., Tylavsky, F. A., Rubin, S. M., Harris, T. B., et al. (2003) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2003.51534.x · Cited by 981
Lean body mass estimation by bioelectrical impedance analysis: a four-site cross-validation study
Segal, K., Van Loan, M., Fitzgerald, P., Hodgdon, A., & Van Itallie, T. (1988) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/47.1.7 · Cited by 881
Cited by
Cruz-Jentoft, A. J., & Sayer, A. A. (2019) · The Lancet · doi:10.1016/s0140-6736(19)31138-9 · Cited by 3,905
Sarcopenia and Cardiovascular Diseases
Damluji, A. A., Alfaraidhy, M., AlHajri, N., Rohant, N. N., Kumar, M., Al Malouf, C., Bahrainy, S., Ji Kwak, M., Batchelor, W. B., Forman, D. E., et al. (2023) · Circulation · doi:10.1161/circulationaha.123.064071 · Cited by 645
Self-citationPathogenesis of sarcopenia and the relationship with fat mass: descriptive review
Li, C., Yu, K., Shyh‐Chang, N., Jiang, Z., Liu, T., Ma, S., Luo, L., Guang, L., Liang, K., Ma, W., et al. (2022) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12901 · Cited by 626
Donini, L. M., Busetto, L., Bauer, J. M., Bischoff, S., Boirie, Y., Cederholm, T., Cruz-Jentoft, A. J., Dicker, D., Frühbeck, G., Giustina, A., et al. (2020) · Clinical Nutrition · doi:10.1016/j.clnu.2019.11.024 · Cited by 326
Advances in muscle health and nutrition: A toolkit for healthcare professionals
Prado, C. M., Landi, F., Chew, S. T. H., Atherton, P. J., Molinger, J., Ruck, T., & Gonzalez, M. C. (2022) · Clinical Nutrition · doi:10.1016/j.clnu.2022.07.041 · Cited by 237
Multisystem physiological perspective of human frailty and its modulation by physical activity
Taylor, J. A., Greenhaff, P. L., Bartlett, D. B., Jackson, T. A., Duggal, N. A., & Lord, J. M. (2023) · Physiological Reviews · doi:10.1152/physrev.00037.2021 · Cited by 197
Coletta, G., & Phillips, S. M. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101883 · Cited by 193
“…(D)-labelled creatine (D3-creatine; D3-Cr), which, when taken up by skeletal muscle, is irreversibly converted to creatinine, can be an accurate measure of SMM (Cawthon et al., 2019; Clark et al., 2018, 2014; Duchowny et al., 2020; Evans et al., 2019; Orwoll et al., 2020; Zanker et al., 2020).”
BackgroundAssociation between serum FGF21 level and sarcopenia in older adults
Jung, H.-W., Park, J. H., Kim, D. A., Jang, I.-Y., Park, S. J., Lee, J. Y., Lee, S., Kim, J. H., Yi, H.-S., Lee, E., et al. (2021) · Bone · doi:10.1016/j.bone.2021.115877 · Cited by 55
Zebrafish models of sarcopenia
Daya, A., Donaka, R., & Karasik, D. (2020) · Disease Models & Mechanisms · doi:10.1242/dmm.042689 · Cited by 55
“A novel approach, based on the dilution of an oral dose of creatinine-(methyl-deuterium, D 3 ) [termed D 3 -Cr dilution] determined by D 3 -Cr enrichment in urine, is receiving increasing attention for its potential application to quantify muscle mass (Evans et al., 2019).”
Zanker, J., Patel, S., Blackwell, T., Duchowny, K., Brennan-Olsen, S., Cummings, S. R., Evans, W. J., Orwoll, E. S., Scott, D., Vogrin, S., et al. (2020) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2020.03.017 · Cited by 40
Self-citationZhu, K., Wactawski-Wende, J., Ochs-Balcom, H. M., LaMonte, M. J., Hovey, K. M., Evans, W., Shankaran, M., Troen, B. R., & Banack, H. R. (2021) · The Journals of Gerontology: Series A · doi:10.1093/gerona/glab020 · Cited by 37
“The D3Cr protocol has been described previously (5,10).”
MethodSelf-citationWages, N. P., Simon, J. E., Clark, L. A., Amano, S., Russ, D. W., Manini, T. M., & Clark, B. C. (2020) · BMC Geriatrics · doi:10.1186/s12877-020-01656-y · Cited by 27
Asano, Y., Yoshida, T., Tsunoda, K., Yokoyama, K., Watanabe, Y., Yoshinaka, Y., Okura, T., Kimura, M., & Yamada, Y. (2025) · Experimental Gerontology · doi:10.1016/j.exger.2025.112862 · Cited by 19
Fielding, R. A., Dao, M. M., Cannon, K., Desvarieux, M., Miller, S. S., Gimness, M. P., Brandon, D. M., Villareal, D. T., Bruyere, O., Bautmans, I., et al. (2025) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.13750 · Cited by 16
Paquin, J., Tremblay, R., Islam, H., Riesco, E., Marcotte-Chénard, A., & Dionne, I. J. (2024) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2024-0128 · Cited by 7
Cataldi, D., Bennett, J. P., Quon, B. K., Leong, L., Kelly, T. L., Evans, W. J., Prado, C. M., Heymsfield, S. B., & Shepherd, J. A. (2023) · doi:10.1101/2023.05.17.23288849 · Cited by 9
Self-citation
Metadata
- Authors
- Evans, W. J., Hellerstein, M., Orwoll, E., Cummings, S., & Cawthon, P. M.
- Venue
- Journal of Cachexia, Sarcopenia and Muscle
- Publisher
- Wiley
- Published
- 2019-02
- Volume
- 10
- Issue
- 1
- Pages
- 14-21
- ISSN
- 2190-5991 (ISSN-L)
- 2190-6009
- OpenAlex
- W2924881952
- Cited by
- 176
- References
- 25
- FWCI
- 13.29
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.